Vijay Madhukar Singavarapu

All articles by Vijay Madhukar Singavarapu

1. M&As this week: Strides Pharma Science, Lambda Therapeutic Research, NextPharma

   Strides Pharma Science’s step-down subsidiary Strides Pharma has made an arrangement to acquire Vensun Pharmaceuticals for $18m. Strides has agreed…
   Read More…

   1 Feb
2. Deals this week: Medicines for Malaria Venture, Swedish Orphan Biovitrum, aTyr Pharma

   Medicines for Malaria Venture (MMV) has entered a collaboration with Drugs for Neglected Disease initiative (DNDi) to create a pandemic…
   Read More…

   1 Feb
3. Deals and M&As this week: Alnylam Pharmaceuticals, Novartis

   Alnylam Pharmaceuticals has entered an agreement with Medison Pharma to commercialise its RNAi therapeutic Onpattro in Israel. Onpattro is indicated…
   Read More…

   25 Jan
4. M&As this week: ProKidney, Quest Products, Gencore Pacific

   ProKidney has acquired inRegen and its subsidiary Twin City Bio. ProKidney has arranged an initial capital of $75m for financing…
   Read More…

   18 Jan
5. Deals this week: Sanofi, Knight Therapeutics, Ascletis Pharma

   Sanofi has gained access to Biomunex Pharmaceuticals’ Plug-and-Play BiXAb platform through a licensing agreement. Sanofi will use the platform to…
   Read More…

   18 Jan
6. M&As this week: Takeda, Eli Lilly, Claudio Bidco

   Takeda Pharmaceutical has completed an acquisition of Shire for $62bn. The acquisition was approved by the shareholders of Takeda in December…
   Read More…

   11 Jan
7. Deals this week: Sanofi, Biogen, Janssen Pharmaceuticals

   Sanofi and Regeneron Pharmaceuticals have entered a revised agreement for the development of novel cancer treatments. The revisions build upon…
   Read More…

   11 Jan
8. Deals and M&As this week: EQT, Sanofi, Bristol-Myers Squibb

   EQT has agreed to increase its acquisition offer for Karo Pharma to Skr6.15bn ($694m) through the EQT VIII fund. The…
   Read More…

   4 Jan
9. M&As this week: Astellas Pharma, Taisho Pharmaceuticals, AMAG Pharmaceuticals

   Astellas Pharma has completed the acquisition of Potenza Therapeutics for $405m. Astellas made an upfront payment of $164.6m and has…
   Read More…

   21 Dec
10. Deals this week: GlaxoSmithKline, Incyte, Novo Nordisk

    GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses with combined annual sales of £9.8bn ($12.7bn) and…
    Read More…

    21 Dec